Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN
Qidi Zheng, Zhuojia Lin, Jie Xu, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

PKM2, function and expression and regulation
Ze Zhang, Xinyue Deng, Yuanda Liu, et al.
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 356
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Yu‐Chin Liu, Chau‐Ting Yeh, Kwang‐Huei Lin
Cells (2020) Vol. 9, Iss. 6, pp. 1331-1331
Open Access | Times Cited: 207
Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a
Xiaoru Xin, Mengying Wu, Qiuyu Meng, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 179
MEG3: an Oncogenic Long Non-coding RNA in Different Cancers
Arwa Al-Rugeebah, Mohammed Alanazi, Narasimha Reddy Parine
Pathology & Oncology Research (2019) Vol. 25, Iss. 3, pp. 859-874
Closed Access | Times Cited: 177
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics
Susi Zhu, Yeye Guo, Xu Zhang, et al.
Cancer Letters (2020) Vol. 503, pp. 240-248
Closed Access | Times Cited: 164
Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy
Xin Huang, Wei Wu, Doudou Jing, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 107-117
Closed Access | Times Cited: 111
Targeting and engineering long non-coding RNAs for cancer therapy
Michela Coan, Simon Haefliger, Samir Ounzain, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 578-595
Closed Access | Times Cited: 68
Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect
Saurabh Upadhyay, Shumayila Khan, Md. Imtaiyaz Hassan
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189089-189089
Closed Access | Times Cited: 17
Long noncoding RNAs in cancer: From discovery to therapeutic targets
Ramesh Choudhari, Melina Sedano, Alana L. Harrison, et al.
Advances in clinical chemistry (2019), pp. 105-147
Closed Access | Times Cited: 124
Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
Nuozhou Wang, Shanshan Wang, Mingyue Li, et al.
Therapeutic Advances in Medical Oncology (2018) Vol. 10
Open Access | Times Cited: 101
Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis
Fangfang Zha, Xiaolu Qu, Bo Tang, et al.
Aging (2019) Vol. 11, Iss. 11, pp. 3716-3730
Open Access | Times Cited: 81
Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications
Zhenkun Lin, Nirmal Goswami, Tiantian Xue, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 51
Closed Access | Times Cited: 67
The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
Dexter Puckett, Mohammed Alquraishi, Winyoo Chowanadisai, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1171-1171
Open Access | Times Cited: 62
A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers
Jie Xu, Xia Wang, Chunming Zhu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 41
Behind the scenes: How RNA orchestrates the epigenetic regulation of gene expression
Arianna Mangiavacchi, Gabriele Morelli, Valerio Orlando
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 36
HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
Ke Li, Quan Gong, Xudong Xiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia
Zi-ye Li, Lin Yang, Xiaojun Liu, et al.
EBioMedicine (2018) Vol. 34, pp. 61-75
Open Access | Times Cited: 74
Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis
Hongjian Wang, Hui Li, Lei Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 1607-1615
Closed Access | Times Cited: 65
Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy
Amin Mahpour, Alan C. Mullen
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100177-100177
Open Access | Times Cited: 63
MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation
Jason J. Gokey, John Snowball, Anusha Sridharan, et al.
JCI Insight (2018) Vol. 3, Iss. 17
Open Access | Times Cited: 61
Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway
GuanXiong Ye, Yong Qin, Wang Shi, et al.
Cancer Biology & Therapy (2019) Vol. 20, Iss. 5, pp. 711-719
Open Access | Times Cited: 57
Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology
Rahul Kumar Mahato, Srinjan Bhattacharya, Naina Khullar, et al.
Journal of Biotechnology (2023) Vol. 379, pp. 98-119
Closed Access | Times Cited: 17
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 8
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells
Kang Wang, Yan Lu, Haibin Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells
Shuqiang Feng, Xing‐Yi Zhang, Haitao Fan, et al.
Neoplasma (2018) Vol. 65, Iss. 06, pp. 925-932
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top